Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

522
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
522
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

868
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

939
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
939
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

283
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

212
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
212
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

289
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria.

American journal of medical genetics. Part A·2026
Same author

Risk of Ocular Comorbidities in Patients With Inherited Retinal Diseases.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Implementation and Assessment of a Novel Interprofessional Educational Initiative in the Medical Intensive Care Unit: A Mixed-Methods Evaluation.

ATS scholar·2026
Same author

Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

Journal of vitreoretinal diseases·2026
Same author

Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease.

Investigative ophthalmology & visual science·2026
Same author

A family with Knobloch syndrome.

Ophthalmic genetics·2025

Related Experiment Video

Updated: Jan 22, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

983

Stickler syndrome: exploring prophylaxis for retinal detachment.

Razek Georges Coussa1, Jonathan Sears, Elias I Traboulsi

  • 1Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Current Opinion in Ophthalmology
|July 18, 2019
PubMed
Summary
This summary is machine-generated.

Stickler syndrome frequently causes rhegmatogenous retinal detachment (RRD) in children, but evidence for prophylactic laser treatment remains insufficient. Further research is needed to establish guidelines for preventing RRD in these patients.

More Related Videos

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.4K

Related Experiment Videos

Last Updated: Jan 22, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

983
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.4K

Area of Science:

  • Ophthalmology
  • Genetics
  • Rheumatology

Background:

  • Stickler syndrome is a hereditary collagen disorder impacting the eyes, ears, and skeleton.
  • It is a leading genetic cause of pediatric rhegmatogenous retinal detachment (RRD).
  • Over half of RRDs in children under 10 are due to congenital anomalies, often linked to Stickler syndrome.

Purpose of the Study:

  • To critically analyze the current literature on prophylactic treatment for rhegmatogenous retinal detachment (RRD) in Stickler syndrome.
  • To evaluate the controversial role of prophylactic interventions in preventing RRD in affected individuals.

Main Methods:

  • Systematic review of major published clinical studies.
  • Critical analysis of existing evidence on prophylactic treatment for RRD in Stickler syndrome.

Main Results:

  • Sixty percent of individuals with Stickler syndrome develop RRD during their lifetime, risking severe vision loss.
  • Prophylactic laser treatment is suggested by some to reduce RRD occurrence, but robust data supporting its absolute benefit is lacking.
  • Current guidelines for prophylactic treatment timing, type, and frequency are scarce.

Conclusions:

  • Stickler syndrome is a significant risk factor for RRD, leading to potential lifelong visual impairment.
  • The efficacy of prophylactic treatment for RRD in Stickler syndrome requires further investigation.
  • Additional clinical studies are necessary to develop evidence-based guidelines for managing RRD risk in Stickler syndrome patients.